FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia
Pioneering CAR T-cell Studies Led to First-ever Cancer Cell and Gene Therapy Approval
August 30, 2017
August 30, 2017
PHILADELPHIA – In a landmark decision for the field of cancer immunotherapy, the U.S. Food and Drug Administration (FDA) today approved a personalized cellular therapy developed by the University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP)…Read Full Article >>
